Association of alterations in homologous recombination repair genes with survival and chemotherapy sensitivity in patients with high-grade serous ovarian cancer

被引：0
作者：
Khan, Sofia [1 ,2 ]
Nevanlinna, Heli [1 ,2 ]
机构：
[1] Univ Helsinki, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Helsinki, Finland
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3107
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3107
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma
    Hisamitsu Takaya
    Hidekatsu Nakai
    Shiro Takamatsu
    Masaki Mandai
    Noriomi Matsumura
    [J]. Scientific Reports, 10
  • [42] Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
    Elorbany, Samar
    Berlato, Chiara
    Carnevalli, Larissa S.
    Maniati, Eleni
    Barry, Simon T.
    Wang, Jun
    Manchanda, Ranjit
    Kzhyshkowska, Julia
    Balkwill, Frances
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01)
  • [43] Neoadjuvant treatment as a window to chemotherapy driven alterations to the genome and transcriptome of high-grade serous ovarian cancer
    Javellana, Melissa
    Eckert, Mark
    Stock, Elizabeth
    Chapel, David
    Lastra, Ricardo
    Lengyel, Ernst
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S210 - S210
  • [44] Development and validation of nomograms to predict survival in patients with high-grade serous ovarian cancer
    Peng, X.
    Liu, J.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S531 - S531
  • [45] Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer
    van Wagensveld, Lilian
    van Baal, Juliette O. A. M.
    Timmermans, Maite
    Gaillard, Duco
    Borghuis, Lauri
    Coffelt, Seth B.
    Rosenberg, Efraim H.
    Lok, Christianne A. R.
    Nijman, Hans W.
    Kooreman, Loes F. S.
    Sanders, Joyce
    de Bruijn, Marco
    Wessels, Lodewyk F. A.
    van der Wiel, Rianne
    Rausch, Christian
    Broeks, Annegien
    Kruitwagen, Roy F. P. M.
    van der Aa, Maaike A.
    Sonke, Gabe S.
    Schouten, Philip C.
    van de Vijver, Koen K.
    Horlings, Hugo M.
    [J]. CANCERS, 2022, 14 (23)
  • [46] HOMOLOGOUS RECOMBINATION DEFICIENCY DETERMINATION IN PATIENTS WITH HIGH-GRADE SEROUS OVARIAN CANCER: REAL-WORD EXPERIENCE IN THE FRENCH CANCER INSTITUTE OF LORRAINE
    Harle, Alexandre
    Husson, Marie
    Hanriot, Idrissia
    Pax, Guillaume
    Gilson, Pauline
    Merlin, Jean-Louis
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A321 - A321
  • [47] HOMOLOGOUS RECOMBINATION DEFICIENCY AND CYCLIN E1 AMPLIFICATION ARE CORRELATED WITH IMMUNE CELL INFILTRATION AND SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER
    Van Wagensveld, Lilian
    Van Baal, Julliete
    Timmermans, Maite
    Gaillard, Duco
    Borghuis, Lauri
    Coffelt, Seth
    Rosenberg, Effraim
    Lok, Christianne
    Nijman, Hans
    Kooreman, Loes
    Broeks, Annegien
    Sanders, Joyce
    De Bruijn, Marco
    Van der Wiel, Rianne
    Kruitwagen, Roy
    Van der Aa, Maaike
    Sonke, Gabe
    Schouten, Philip
    Van de Vijver, Koen
    Horlings, Hugo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A47 - A47
  • [48] Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over
    Pitiyarachchi, Omali
    Ansell, Peter J.
    Coleman, Robert L.
    Dinh, Minh H.
    Holman, Laura
    Leath III, Charles A.
    Werner, Theresa
    Disilvestro, Paul
    Morgan, Mark
    Tew, William
    Lee, Christine
    Cunningham, Mary
    Newton, Meredith
    Edraki, Babak
    Lim, Peter
    Barlin, Joyce
    Spirtos, Nicola M.
    Tewari, Krishnansu S.
    Edelson, Mitchell
    Reid, Thomas
    Carlson, Jay
    Friedlander, Michael
    [J]. GYNECOLOGIC ONCOLOGY, 2024, 187 : 221 - 226
  • [49] Liquid biopsy for the determination of homologous recombination deficiency in patients with high-grade serous ovarian cancer: Results of the BOVARY-pilot study
    Harle, A.
    Husson, M.
    Michel, C.
    Hanriot, I.
    Gilson, P.
    Dardare, J.
    Witz, A.
    Betz, M.
    Leroux, A.
    Merlin, J. L.
    Gavoille, C.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S584 - S584
  • [50] Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status
    Li, Yongmei
    Nie, Yufei
    Guo, Hongyan
    Guo, Hua
    Ha, Chunfang
    Li, Yuan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345